Heart Failure
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who were admitted our hospital Age greater than or equal to 20 years old Obtained written informed consent
Exclusion criteria
Exclusion criteria: (1) patients with liver cirrhosis (2) patients with dialysis (3) patients with acute coronary syndrome (4) patients with hematopoietic disorders (5) patients with portal hypertension (6) patients with acute viral infection (i.e. EB virus) (7) patients with splenomegaly due to infection (i.e. tuberculosis, malaria, and brucellosis) (8) patients with splenomegaly due to accumulation diseases (9) patients with splenomegaly due to autoimmune disorders (10) patients who can not be performed MRI (11) patients with arteriosclerosis obliterans in lower limb
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiovascular death | — |
Secondary
| Measure | Time frame |
|---|---|
| Composite endpoint included all-cause death, cardiovascular death, and heart failure readmission and rates of each event. Serum BNP level. | — |
Countries
Japan
Contacts
Showa University Northern Yokohama Hospital Division of Cardiology and Cardiac Catheterization Laboratories